Medicover first in Europe to launch pilot project aimed at identifying patients at risk of colorectal cancer

Medicover first in Europe to launch pilot project aimed at identifying patients at risk of colorectal cancer

Published

Medicover Polska is testing the ColonFlag modern solution that will allow to effectively identify patients at risk for colorectal cancer. The tool determines the risk of intestinal lesions by further analysing the results of a commonly performed blood test. The pilot project is being developed in collaboration with Medial EarlySign, an Israeli company that creates machine-learning systems in the area of data-driven medicine.

ColonFlag is a solution that identifies patients who may experience gastrointestinal microbleeding caused by polyps or cancer. A positive result is an indication for colonoscopy.

ColonFlag helps make diagnostic decisions thanks to applying advanced AI algorithms to data from frequently performed laboratory tests. The programme analyses data such as the results of a CBC test and other data contained in electronic medical records.

- Dr Piotr Soszyński, Director of Medical Systems at Medicover Polska

This makes it possible for the tool to identify people who are in a high risk group and require further testing.

Colon cancer is the second most common cancer in women in Poland and the third among males. It is the fourth most common cause of death due to cancer. In Poland, the average survival rate after five years is slightly below 50%. If colorectal cancer is diagnosed at an early stage, the rate may even exceed 90%. Early detection has enormous importance for the successful treatment of colorectal cancer. ColonFlag can help us better identify patients in the high risk group. Thanks to this, referrals for colonoscopy may result in a better chance of detecting the disease and significantly improve the outcome of treatment.

- Dr Bożena Walewska-Zielecka, Medical Director at Medicover Polska

The success of the project may mean that Medicover Polska will begin using the ColonFlag tool in routine diagnostic procedures.

We are pleased to be working with Medicover on their first use of machine-learning algorithms to streamline the processes of diagnostic decision making. This is the first step towards integrating technology that will have a far-reaching impact on the work of doctors and medical service providers. It will give them tools to provide individualised care for patients in the high risk group. - Ori Geva, CEO of Medial EarlySign.
The pilot programme using the innovative method is being implemented at Medicover Centres in Warsaw and in the south of Poland. The single analysis is performed in Medicover patients between the ages of 50 and 75 who have had a complete blood count test performed for any reasons and agreed to participate in the project. Medial EarlySign is currently conducting clinical trials in more than 20 million patients in 14 institutions around the world.

Copy as a Plain Text

Share

Related Stories
Accidents at work. The first 10 minutes are crucial.

ago

By the end of September 2017, more than 56,100 persons were injured as a consequence of accidents at work. According to the data of the Central Statistical Office, the most accident-prone sectors included industrial processing, trade, transport, storage, and construction. Due to their inability to work, employees collectively spent more than 1.8 million days on sick leaves – this is more than 33 days per one injured person. In many situations, the consequences of the accident could have been much less serious if appropriate aid was provided immediately. Human health and lives frequently depend on whether employees (or witnesses of an accident) are able to react properly and provide first aid.
More than half of Poles are treated at private dental offices

ago

The Polish dental market, following the example of the European market, is in the process of consolidation. Small offices are increasingly joining large networks. This is taking place to meet the expectations of patients who value quality services, convenience, trust in doctors, and modern office equipment. In Poland, this market has been dominated by private entities that can afford expensive investments (as public spending on dentistry makes up only 2.5 percent of the entire National Health Fund budget). Over half of Polish patients are treated by private entities.
Pregnabit at Medicover Poland medical centres

ago

Nestmedic has signed a contract with an international private healthcare company. The mobile CTG system, Pregnabit, will be launched at Medicover Poland medical centres. This launch will mark the beginning of further contracts with international medical networks.
More and more small and medium companies are investing in medical care for employees

ago

According to the latest Eurostat data, Poland is in the top five countries of the European Union with the lowest unemployment rate. Although on one hand these statistics are a cause for joy, they also pose a big challenge for many employers, who are having a harder time finding good employees these days. In order to be competitive on the market, you have to offer attractive non-financial benefits. At the top of the candidates' list of expectations is private medical care – as many as 14 percent of them declare it important. And although it is already a standard in corporations, it is still a big challenge for small and micro-enterprises, in which only 6 percent of employees are covered by private medical care. Why is it worth investing in it?

Healthy baby - the challenge of modern times

In 2016, over 382,000 births were recorded in Poland [1]. Research shows that two thirds of parents feed their children the wrong diet and expand their children’s diet too quickly [2]. The knowledge on how to take proper care of infants is still insufficient, which increases the risk of disease in later years. That is why regular medical check-ups for a newborn baby are so important to ensure that his health and development are constantly assessed. Constant paediatric care also enables parents to deepen their knowledge about the best ways to take care of their child's health.